UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Pegylated liposomal doxorubicin (PLD) in daily practice—A single center experience of treatment with PLD in patients with comorbidities and older patients with metastatic breast cancer

Cancer medicine (Malden, MA), 2023-06, Vol.12 (12), p.13388-13396

2023

Volltextzugriff (PDF)

Focusing on cancer patients' intentions to use psychooncological support: A longitudinal, mixed‐methods study

Psycho-oncology (Chichester, England), 2018-06, Vol.27 (6), p.1656-1663

2018

Volltextzugriff (PDF)

Targeting immunoliposomes to EGFR-positive glioblastoma

ESMO open, 2022-02, Vol.7 (1), p.100365-100365, Article 100365

2022

Volltextzugriff (PDF)

Somatostatin-based radiopeptide therapy with [177Lu-DOTA]-TOC versus [90Y-DOTA]-TOC in neuroendocrine tumours

European journal of nuclear medicine and molecular imaging, 2014-02, Vol.41 (2), p.214-222

2014

Volltextzugriff (PDF)

Do all patients with advanced HER2 positive breast cancer need upfront-chemo when receiving trastuzumab? Randomized phase III trial SAKK 22/99

Annals of oncology, 2017-02, Vol.28 (2), p.305-312

2017

Volltextzugriff (PDF)

Cell fusion: an approach to generating constitutively proliferating human tumor antigen-presenting cells

Cancer Immunology, Immunotherapy, 2002-09, Vol.51 (7), p.367-375

2002

Volltextzugriff (PDF)

1943 Adjuvant treatment recommendations for ER+ early breast cancer patients by Swiss tumor boards (SAKK 26/10)

European journal of cancer (1990), 2015-09, Vol.51, p.S313-S313

2015

Volltextzugriff (PDF)

Adenovirus-Mediated Wild-Type p53 Gene Transfer in Patients Receiving Chemotherapy for Advanced Non–Small-Cell Lung Cancer: Results of a Multicenter Phase II Study

Journal of clinical oncology, 2001-03, Vol.19 (6), p.1750-1758

2001

Volltextzugriff (PDF)

Combination of bevacizumab and 2-weekly pegylated liposomal doxorubicin as first-line therapy for locally recurrent or metastatic breast cancer. A multicenter, single-arm phase II trial (SAKK 24/06)

Annals of oncology, 2011-01, Vol.22 (1), p.80-85

2011

Volltextzugriff (PDF)

Toxic Encephalopathy Induced by Capecitabine

Oncology, 2004-01, Vol.66 (4), p.331-335

2004

Volltextzugriff (PDF)

Gene therapy of cancer

Swiss medical weekly, 2001-01, Vol.131 (1-2), p.4

Rochlitz, C F

2001

Volltextzugriff (PDF)

Phase I immunotherapy with a modified vaccinia virus (MVA) expressing human MUC1 as antigen-specific immunotherapy in patients with MUC1-positive advanced cancer

The journal of gene medicine, 2003-08, Vol.5 (8), p.690-699

2003

Volltextzugriff (PDF)

Amplification of SKI Is a Prognostic Marker in Early Colorectal Cancer

Neoplasia (New York, N.Y.), 2004-05, Vol.6 (3), p.207-212

2004

Volltextzugriff (PDF)

SIOG2022-0076 - Pegylated liposomal doxorubicin (PLD) in daily practice – A single center experience of treatment with PLD in elderly and co-morbid patients with metastatic breast cancer

Journal of geriatric oncology, 2022-10, Vol.13 (8), p.S8-S9

2022

Volltextzugriff (PDF)

Pegylated liposomal doxorubicin (PLD) in daily practice – A single center experience of treatment with PLD in elderly and co-morbid patients with metastatic breast cancer

Journal of geriatric oncology, 2022-10, Vol.13 (8), p.S8-S9

2022

Volltextzugriff (PDF)

SMAD4 is a predictive marker for 5-fluorouracil-based chemotherapy in patients with colorectal cancer

British journal of cancer, 2002-09, Vol.87 (6), p.630-634

2002

Volltextzugriff (PDF)

Sentinel lymph node biopsy in primary breast cancer: Trust the radiolabeled colloid method and avoid unnecessary procedures

European journal of surgical oncology, 2011-03, Vol.37 (3), p.211-216

2011

Volltextzugriff (PDF)

Axl expression is associated with adverse prognosis and with expression of Bcl-2 and CD34 in de novo acute myeloid leukemia (AML) : results from a multicenter trial of the Swiss Group for Clinical Cancer Research (SAKK)

Leukemia, 1999-09, Vol.13 (9), p.1352-1358

1999

Volltextzugriff (PDF)

Capecitabine and Vinorelbine as First-Line Treatment in Elderly Patients (≥65 Years) with Metastatic Breast Cancer : A Phase II Trial (SAKK 25/99)

Oncology, 2007-01, Vol.73 (3-4), p.228-237

2007

Volltextzugriff (PDF)

Capecitabine in hormone-resistant metastatic prostatic carcinoma - a phase II trial

British journal of cancer, 2004-04, Vol.90 (7), p.1312-1317

2004

Volltextzugriff (PDF)

Scope and significance of non-uniform classification practices in breast cancer with non-inflammatory skin involvement: a clinicopathologic study and an international survey

Annals of oncology, 2005-10, Vol.16 (10), p.1618-1623

2005

Volltextzugriff (PDF)

268P Anti-EGFR-immunoliposomes loaded with doxorubicin in patients with advanced triple-negative, EGFR positive breast cancer: A multicenter single arm phase II trial [SAKK 24/14]

Annals of oncology, 2021-09, Vol.32, p.S479-S479

2021

Volltextzugriff (PDF)

Serious Complications Associated with External Intrathecal Catheters Used in Cancer Pain Patients: A Systematic Review and Meta-analysis

Anesthesiology (Philadelphia), 2009-12, Vol.111 (6), p.1346-1355

2009

Volltextzugriff (PDF)

Communication skills training in oncology: a position paper based on a consensus meeting among European experts in 2009

Annals of oncology, 2010-02, Vol.21 (2), p.204-207

2010

Volltextzugriff (PDF)

Overexpression and amplification of c-myc during progression of human colorectal cancer

Oncology, 1996-11, Vol.53 (6), p.448-454

1996

Volltextzugriff (PDF)

1 – 25 von 212

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(177)
Mit Volltextzugriff
(162)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(151)
Französisch
(49)
Deutsch
(12)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Pegylated liposomal doxorubicin (PLD) in daily practice—A single center experience of treatment with PLD in patients with comorbidities and older patients with metastatic breast cancer

Focusing on cancer patients' intentions to use psychooncological support: A longitudinal, mixed‐methods study

Targeting immunoliposomes to EGFR-positive glioblastoma

Somatostatin-based radiopeptide therapy with [177Lu-DOTA]-TOC versus [90Y-DOTA]-TOC in neuroendocrine tumours

Do all patients with advanced HER2 positive breast cancer need upfront-chemo when receiving trastuzumab? Randomized phase III trial SAKK 22/99

Cell fusion: an approach to generating constitutively proliferating human tumor antigen-presenting cells

1943 Adjuvant treatment recommendations for ER+ early breast cancer patients by Swiss tumor boards (SAKK 26/10)

Adenovirus-Mediated Wild-Type p53 Gene Transfer in Patients Receiving Chemotherapy for Advanced Non–Small-Cell Lung Cancer: Results of a Multicenter Phase II Study

Combination of bevacizumab and 2-weekly pegylated liposomal doxorubicin as first-line therapy for locally recurrent or metastatic breast cancer. A multicenter, single-arm phase II trial (SAKK 24/06)

Toxic Encephalopathy Induced by Capecitabine

Gene therapy of cancer

Phase I immunotherapy with a modified vaccinia virus (MVA) expressing human MUC1 as antigen-specific immunotherapy in patients with MUC1-positive advanced cancer

Amplification of SKI Is a Prognostic Marker in Early Colorectal Cancer

SIOG2022-0076 - Pegylated liposomal doxorubicin (PLD) in daily practice – A single center experience of treatment with PLD in elderly and co-morbid patients with metastatic breast cancer

Pegylated liposomal doxorubicin (PLD) in daily practice – A single center experience of treatment with PLD in elderly and co-morbid patients with metastatic breast cancer

SMAD4 is a predictive marker for 5-fluorouracil-based chemotherapy in patients with colorectal cancer

Sentinel lymph node biopsy in primary breast cancer: Trust the radiolabeled colloid method and avoid unnecessary procedures

Axl expression is associated with adverse prognosis and with expression of Bcl-2 and CD34 in de novo acute myeloid leukemia (AML) : results from a multicenter trial of the Swiss Group for Clinical Cancer Research (SAKK)

Capecitabine and Vinorelbine as First-Line Treatment in Elderly Patients (≥65 Years) with Metastatic Breast Cancer : A Phase II Trial (SAKK 25/99)

Capecitabine in hormone-resistant metastatic prostatic carcinoma - a phase II trial

Scope and significance of non-uniform classification practices in breast cancer with non-inflammatory skin involvement: a clinicopathologic study and an international survey

268P Anti-EGFR-immunoliposomes loaded with doxorubicin in patients with advanced triple-negative, EGFR positive breast cancer: A multicenter single arm phase II trial [SAKK 24/14]

Serious Complications Associated with External Intrathecal Catheters Used in Cancer Pain Patients: A Systematic Review and Meta-analysis

Communication skills training in oncology: a position paper based on a consensus meeting among European experts in 2009

Overexpression and amplification of c-myc during progression of human colorectal cancer

Suchergebnisse filtern